Press release
Lawsuit filed for Investors who lost money with shares of Everus Construction Group, Inc. (NYSE: ECG)
An investor, who purchased shares of Everus Construction Group, Inc. (NYSE: ECG), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Everus Construction Group, Inc. in connection with certain allegedly false and misleading statements.Investors who purchased shares of Everus Construction Group, Inc. (NYSE: ECG) have certain options and for certain investors are short and strict deadlines running. Deadline: June 3, 2025. NYSE: ECG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Bismarck, ND based Everus Construction Group, Inc. provides contracting services in the United States. On February 11, 2025, after the market closed, Everus released its fourth quarter and full year 2024 financial results.
Everus Construction Group also revealed that "[g]iven the current mix of [the Company's] backlog," its "backlog conversion" would be "extended relative to [the] historical pattern over the coming quarters." The Company explained its average project size had been getting "larger, more complex and longer." The Company further revealed that, as a result of this shift in backlog composition, "heading into 2025" the Company "expect[s] revenue in the range of $3.0 billion to $3.1 billion and EBITDA in the range of $210 million to $225 million for the year."
Shares of Everus Construction Group, Inc. (NYSE: ECG) declined from $77.93 per share on January 24, 2025, to as low as $31.38 per share on April 04, 2025.
The plaintiff claims that between October 31, 2024 and February 11, 2025, the Defendants failed to disclose to investors that the Company's backlog conversion cycle had become elongated due to larger, more complex projects, that as a result, the Company's revenue recognition would be delayed, and thatas a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Everus Construction Group, Inc. (NYSE: ECG) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Everus Construction Group, Inc. (NYSE: ECG) here
News-ID: 3974760 • Views: …
More Releases from Shareholders Foundation

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Investor Alert: Deadline in Lawsuit …
A deadline is coming up on May 26, 2025 in the lawsuit filed for certain investors of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) over alleged securities laws violations by Actinium Pharmaceuticals, Inc.
Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) have certain options and there are strict and short deadlines running. Deadline: May 26, 2025. Actinium Pharmaceuticals, Inc. (NYSE: ATNM) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…

Investigation announced for Long-Term Investors in shares of Rocket Lab USA, Inc …
An investigation was announced for long-term investors in shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) concerning potential breaches of fiduciary duties by certain directors of Rocket Lab USA, Inc.
Investors who are current long term investors in Rocket Lab USA, Inc. (NASDAQ: RKLB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…

TFI International Inc. (NYSE: TFII) Investor Alert: Deadline in Lawsuit on May 1 …
A deadline is coming up on May 13, 2025 in the lawsuit filed for certain investors of TFI International Inc. (NYSE: TFII) over alleged securities laws violations by TFI International Inc.
Investors who purchased shares of TFI International Inc. (NYSE: TFII) have certain options and there are strict and short deadlines running. Deadline: May 13, 2025. TFI International Inc. (NYSE: TFII) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…

Investigation announced for Long-Term Investors in shares of Icon Energy Corp. ( …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Icon Energy Corp.
Investors who are current long term investors in Icon Energy Corp. (NASDAQ: ICON) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ICON stocks follows a lawsuit filed against Icon…
More Releases for Everus
p2pb2b Exchange: TOP-10 Projects to Invest in February 2019
Since the beginning of 2019, already over $28 million was raised by new crypto-based projects as it is stated in the ICOdata statistics. The simplest way to support the ideas and ensure your future ROI is to buy project’s tokens on the cryptocurrency exchange. Reliable trading platform mostly lists only credible coins, so as long as you trust the exchange of your choice, you may trust the currencies they enlist.…